Medical Uses
JYLAMVO (methotrexate oral solution) is a ready-to-use liquid formulation of methotrexate indicated for the treatment of severe active rheumatoid arthritis in adults, and polyarticular juvenile idiopathic arthritis, as well as severe, recalcitrant, disabling psoriasis in adults not adequately responsive to other therapies. It is also used in certain oncology protocols under specialist supervision.
Methotrexate is a folate antagonist that inhibits dihydrofolate reductase, interfering with DNA synthesis and cell replication. In rheumatologic and dermatologic conditions, it also has immunomodulatory and anti-inflammatory effects at low weekly doses. JYLAMVO’s oral solution format allows precise, flexible dosing compared with tablets.
